The Thera-Business Team
Meet the Team
We are driven and know that our work is of utmost importance to patient care! Our consultants are detail-oriented team players with the ability to work to tight deadlines. We are committed to understanding your needs and providing solutions that contribute to your success.
Dr. Isabella Steffensen
President
Dr. Steffensen is a biomedical scientist with a B.Sc. Honours Biology (cum laude) and Ph.D. in Cellular Biology from the University of Ottawa. She completed a postdoctoral fellowship with a leading neurologist at the Ottawa Health Research Institute where she performed research on stroke and spinal cord injury.
Over the past 25+ years, Dr. Steffensen has assisted pharmaceutical, medical device, biotechnology and diagnostic companies with regulatory, marketing, technical, and business development issues. She has widespread experience preparing regulatory documents, as well as other evidence based-reports such as practice guidelines and systematic reviews. Dr. Steffensen has completed hundreds of projects in the life sciences sector, embracing biotechnology, pharmaceuticals and bio-pharmaceuticals, medical devices, technology and diagnostics. She is a specialist at Clinical Evaluation Report remediation and helping medical device companies fulfill current regulatory requirements in the European Union. Dr. Steffensen is responsible for the overall operations and performance of Thera-Business, where she mentors a highly-skilled group of executives and staff. She is a well-respected leader with the strategic foresight to develop and promote a compelling vision for the future of Thera-Business.
Dr. Red Thaddeus Miguel
Chief Executive Officer
Dr. Miguel has completed an MSc in Evidence-Based Health Care at the University of Oxford, earning a Distinction. He also holds a BSc in Health Sciences from Ateneo de Manila University, and dual degrees of MD and MBA from the Ateneo School of Medicine and Public Health and the Ateneo Graduate School of Business. He also holds the leading credentials of Regulatory Affairs Certification (RAC) in Drugs and the Regulatory Compliance Certification (RCC) for Medical Device Regulation from the Regulatory Affairs Professionals Society (RAPS), highlighting his extensive expertise in regulatory standards for both pharmaceuticals and medical devices.
Dr. Miguel began his career as a University Researcher at the Health Policy Hub and the National Institutes of Health at the University of the Philippines. In this role, he was a key researcher and investigator for several important studies including the national valuation of EQ-5D-5L, the national baseline study on child restraints, the modelling of the burden and cost for hepatitis B and hepatitis C, and the national evaluation of a health insurance package for catastrophic illnesses. Concurrently, he served as a Research Fellow for the Asia Pacific Center for Evidence-Based Healthcare and as a Researcher for Kalusugan ng Mag-Ina, Inc. (Health of Mother and Child), focusing on the methodology of clinical practice guidelines and health insurance packages.
Currently, Dr. Miguel provides leadership at Thera-Business, building roadmaps for health research projects. His work focuses on using resources at Thera-Business to create customized solutions to best meet the clients’ diverse needs. As a specialist in evidence-based practices and health research methodologies, Dr. Miguel oversees a broad range of initiatives at Thera-Business, such as developing regulatory documents, and conducting complex health research analyses, health economics and outcomes research, and real-world evidence studies.
His extensive experience has led to numerous published papers and awards. Notably, he was recently honored as one of the recipients of the prestigious Forty Under 40 award from the Ottawa Business Journal and the Ottawa Board of Trade, recognizing his exceptional business achievements, professional expertise, and impactful community involvement.
Mr. Michael Grimes
Chief Financial Officer
Michael Grimes currently serves as the company’s Chief Financial Officer. Michael earned an MBA degree from the University of Ottawa. He is also a member in good standing of the Institute of Chartered Accountants of Scotland, the Chartered Institute of Management Accountants, and CPA Ontario. Michael also holds a Certified Information Technology Professional (CITP) certification issued by the American Institute of Certified Public Accountants (AICPA).
Mr. Vladimir Kuznetsov
Director of Software Development
Mr. Kuznetsov received his B.Eng. in Electrical Engineering from Carleton University in 2015. Mr. Kuznetsov is an expert with programming languages such as JavaScript, SQL, and PHP. Mr. Kuznetsov has performed multiple subcontracting projects which has allowed him to diversify his knowledge with MongoDB, Express, React, and Node frameworks. During his time at Carleton University studying electrical engineering, Mr. Kuznetsov participated in an internship at Ericsson in Ottawa working on product debugging, as well as testing of logic circuits. In addition to his academic credentials, he has taken multiple courses to update and improve his knowledge on various topics relating to software languages.
Ms. Lindsay Kemp
Director of Operations
Lindsay Kemp has over 14 years of experience in the health sciences sector, where she has accumulated extensive experience managing projects, communicating with clients to understand their needs, preparing and submitting regulatory submissions, and researching and writing reports. Previously, Lindsay has spent time in technology transfer at both the University of Victoria and the Ottawa Hospital Research Institute. As a Technology Transfer Officer and Manager, Lindsay collaborated with faculty, researchers, and students to evaluate, protect and transfer their research and innovations to the private sector. Additionally, she assisted scientists in the planning and preparation of large and small grant applications. Prior to moving to the Business Operations Manager role, Lindsay worked at Thera-Business as a Research Officer, supporting the medical research/writing team, and helping to develop internal best practices adhering to regulatory standards. Previous to working at Thera-Business, Lindsay worked as a senior consultant, providing expertise to pharmaceutical industry clients on government regulations and drug product pricing assessments.
Lindsay Kemp received her MSc from the University of Guelph in Biomedical Science, where her research focused on prothrombin synthesis and thrombin generation in the ovarian follicle. She is a primary author and co-author on several scientific articles in peer-reviewed publications.